![Holger Lembrér](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Holger Lembrér
Finansdirektör/CFO på
ENZYMATICA AB
Profil
Holger Lembrér is currently Chief Financial Officer at Enzymatica AB since 2026.
Formerly, Chief Financial Officer at Boule Diagnostics AB from 2024 to 2026, Chief Financial Officer at Oncopeptides AB in 2023, Chief Financial Officer at ASSA ABLOY.
AB from 2011 to 2019, and Auditor at Ernst & Young AB from 2008 to 2011.
Education includes a graduate degree from the University of Uppsala.
Senaste nyheterna om Holger Lembrér
Aktiva positioner av Holger Lembrér
| Företag | Position | Start |
|---|---|---|
| ENZYMATICA AB | Finansdirektör/CFO | 2026-04-13 |
Tidigare kända positioner av Holger Lembrér
| Företag | Position | Slut |
|---|---|---|
| BOULE DIAGNOSTICS AB | Verkställande Direktör | 2024-04-16 |
| ONCOPEPTIDES AB | Finansdirektör/CFO | 2023-11-13 |
| ASSA ABLOY AB | Finansdirektör/CFO | 2019-04-01 |
Ernst & Young AB
 Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services | Comptroller/Controller/Revisor | 2011-09-01 |
Holger Lembrérs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
69
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Assa Abloy AB
 Assa Abloy AB Tools & HardwareConsumer Durables Manufactures and sells mechanical, electromechanical, digital door locks and smart home access solutions | Consumer Durables |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Boule Diagnostics AB
 Boule Diagnostics AB Medical SpecialtiesHealth Technology Develops, manufactures, and markets medical tools | Health Technology |
Ernst & Young AB
Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services | Commercial Services |
Enzymatica AB
 Enzymatica AB Medical SpecialtiesHealth Technology Develops and sells medical technology products against infectious diseases | Health Technology |
